Data Driven Bioscience (Duoseq)
Data Driven Bioscience is building a faster, cheaper sequencing-based way to diagnose and subtype cancers, starting with lymphoma.
Overview
Data Driven Bioscience, which trades as Duoseq, develops sequencing-based diagnostic assays that read DNA and RNA together to classify cancers more precisely and at lower cost than current pathology workups, with early work in lymphoma subtyping. Its YC pitch was cancer diagnosis ten times faster and ten times cheaper. The company is a Duke University area spin-out and remains active in the YC directory; published clinical validation is limited, so treat the evidence as early.
Funding
All startupsPages like this
not linked directly; found by shared links- CompanyOncobox
Shares Y Combinator, RNA sequencing & expression profiling, Comprehensive genomic profiling and the tag yc.
- CompanyBlank Bio
Shares Y Combinator, RNA sequencing & expression profiling and the tag yc.
- CompanyCambridge Cancer Genomics (CCG.ai)
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyYemaachi Biotech
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyOmanta
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyArpeggio Bio
Shares Y Combinator, RNA sequencing & expression profiling and the tag yc.
- CompanyIsabl
Shares Y Combinator, RNA sequencing & expression profiling and the tag yc.
- CompanyBillionToOne
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.